JP2022507269A5 - - Google Patents
Info
- Publication number
- JP2022507269A5 JP2022507269A5 JP2021525757A JP2021525757A JP2022507269A5 JP 2022507269 A5 JP2022507269 A5 JP 2022507269A5 JP 2021525757 A JP2021525757 A JP 2021525757A JP 2021525757 A JP2021525757 A JP 2021525757A JP 2022507269 A5 JP2022507269 A5 JP 2022507269A5
- Authority
- JP
- Japan
- Prior art keywords
- mir
- sequence
- target sequence
- copies
- recombinant dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862760422P | 2018-11-13 | 2018-11-13 | |
| US62/760,422 | 2018-11-13 | ||
| PCT/US2019/061093 WO2020102285A1 (en) | 2018-11-13 | 2019-11-13 | Encapsulated polynucleotides and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022507269A JP2022507269A (ja) | 2022-01-18 |
| JP2022507269A5 true JP2022507269A5 (https=) | 2022-11-07 |
Family
ID=70731661
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021525757A Pending JP2022507269A (ja) | 2018-11-13 | 2019-11-13 | カプセル化ポリヌクレオチド及び使用方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20210403950A1 (https=) |
| EP (1) | EP3880812A4 (https=) |
| JP (1) | JP2022507269A (https=) |
| KR (1) | KR20210093285A (https=) |
| CN (1) | CN113348246A (https=) |
| AU (1) | AU2019381698A1 (https=) |
| BR (1) | BR112021009226A2 (https=) |
| CA (1) | CA3117924A1 (https=) |
| IL (1) | IL282992A (https=) |
| MX (1) | MX2021005448A (https=) |
| SG (1) | SG11202104887UA (https=) |
| WO (1) | WO2020102285A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11130787B2 (en) * | 2020-06-11 | 2021-09-28 | MBF Therapeutics, Inc. | Alphaherpesvirus glycoprotein d-encoding nucleic acid constructs and methods |
| CA3207753A1 (en) * | 2021-02-10 | 2022-08-18 | Jessica DETERLING | Compounds, compositions, and methods of using thereof |
| IT202200016386A1 (it) * | 2022-08-02 | 2024-02-02 | Univ Degli Studi Roma La Sapienza | Nanoparticelle lipidiche multicomponenti ad elevata fusogenicità cellulare per la veicolazione di acidi nucleici e relativo processo di preparazione |
| EP4658782A2 (en) * | 2023-02-02 | 2025-12-10 | The Regents of the University of California | Self-amplifying non-coding rna for targeted gene knockdown |
| CN121285381A (zh) * | 2023-03-20 | 2026-01-06 | 安娜·迪姆伯格 | 用于癌症治疗的靶向肿瘤血管的aav疗法 |
| CN117487762A (zh) * | 2023-11-06 | 2024-02-02 | 中科佰乘(深圳)生物科技有限公司 | 一种细胞外囊泡、制备方法、药物组合物及应用 |
| CN119242712A (zh) * | 2024-09-27 | 2025-01-03 | 南京师范大学 | 特异性靶向骨骼肌细胞的携带miRNA-486基因的腺相关病毒载体、药物组合物 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1092777A1 (en) * | 1999-10-15 | 2001-04-18 | Aventis Pharma S.A. | Self-cleaving RNA sequences and their use for the control of protein synthesis. |
| AU2002953436A0 (en) * | 2002-12-18 | 2003-01-09 | The University Of Newcastle Research Associates Limited | A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis |
| WO2005028658A2 (en) * | 2003-05-28 | 2005-03-31 | Wisconsin Alumni Research Foundation | Recombinant influenza vectors with a polii promoter and ribozymes |
| MXPA06003318A (es) * | 2003-09-26 | 2006-06-08 | Novartis Ag | Composiciones a base de virus de seneca valley y metodos para tratar la enfermedad. |
| EP1843773A4 (en) * | 2005-01-17 | 2008-07-30 | Viralytics Ltd | METHOD AND COMPOSITION FOR TREATING NEOPLASIA |
| WO2006138380A2 (en) * | 2005-06-15 | 2006-12-28 | Massachusetts Institute Of Technology | Amine-containing lipids and uses thereof |
| WO2016191684A1 (en) * | 2015-05-28 | 2016-12-01 | Finer Mitchell H | Genome editing vectors |
| AU2016274655B2 (en) * | 2015-06-10 | 2021-06-17 | NeoTrail Therapeutics, Inc. | HPV vaccines |
| KR20180136435A (ko) * | 2016-01-27 | 2018-12-24 | 온코루스, 인크. | 종양 살상형 바이러스 벡터 및 그의 용도 |
| AU2017290828A1 (en) * | 2016-06-30 | 2019-01-24 | Virogin Biotech Canada Ltd | Pseudotyped oncolytic viral delivery of therapeutic polypeptides |
| CA3030003A1 (en) * | 2016-07-08 | 2018-01-11 | F1 Oncology, Inc. | Methods and compositions for transducing lymphocytes and regulating the activity thereof |
| AU2017356699B2 (en) * | 2016-11-08 | 2021-11-11 | Ramot At Tel-Aviv University Ltd. | Cationic lipids for nucleic acid delivery and preparation thereof |
| KR20200036873A (ko) * | 2017-07-14 | 2020-04-07 | 온코루스, 인크. | 캡슐화된 폴리뉴클레오티드 및 사용 방법 |
| CA3157063A1 (en) * | 2019-10-10 | 2021-04-15 | Oncorus, Inc. | Dual viruses and dual oncolytic viruses and methods of treatment |
-
2019
- 2019-11-13 MX MX2021005448A patent/MX2021005448A/es unknown
- 2019-11-13 KR KR1020217017630A patent/KR20210093285A/ko not_active Ceased
- 2019-11-13 EP EP19884039.9A patent/EP3880812A4/en not_active Withdrawn
- 2019-11-13 SG SG11202104887UA patent/SG11202104887UA/en unknown
- 2019-11-13 AU AU2019381698A patent/AU2019381698A1/en not_active Abandoned
- 2019-11-13 CN CN201980085641.2A patent/CN113348246A/zh active Pending
- 2019-11-13 JP JP2021525757A patent/JP2022507269A/ja active Pending
- 2019-11-13 WO PCT/US2019/061093 patent/WO2020102285A1/en not_active Ceased
- 2019-11-13 BR BR112021009226-9A patent/BR112021009226A2/pt not_active IP Right Cessation
- 2019-11-13 CA CA3117924A patent/CA3117924A1/en active Pending
- 2019-11-13 US US17/293,153 patent/US20210403950A1/en not_active Abandoned
-
2021
- 2021-05-06 IL IL282992A patent/IL282992A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022507269A5 (https=) | ||
| US11713336B2 (en) | Peptides and nanoparticles for intracellular delivery of molecules | |
| JP2022516318A5 (https=) | ||
| Wu et al. | Chimeric antigen receptor therapy meets mRNA technology | |
| Oveili et al. | The potential use of mesenchymal stem cells-derived exosomes as microRNAs delivery systems in different diseases | |
| JP2021524245A5 (https=) | ||
| Tyagi et al. | Exploiting nanotechnology for the development of microRNA-based cancer therapeutics | |
| Steinle et al. | Delivery of synthetic mRNAs for tissue regeneration | |
| JP2021003105A (ja) | ハイブリッドｔＲＮＡ／プレｍｉＲＮＡ分子および使用方法 | |
| US20250170233A1 (en) | Compositions and methods for organ-protective expression and modulation of coding ribonucleic acids | |
| Wu et al. | MiRNAs in human cancers: the diagnostic and therapeutic implications | |
| CN112533643A (zh) | 外排体用于靶向递送治疗剂的用途 | |
| JP2023528300A5 (https=) | ||
| Yassine et al. | Mesenchymal stem cell exosomes and cancer: controversies and prospects | |
| Dai et al. | Pancreatic cancer: Nucleic acid drug discovery and targeted therapy | |
| Parsel et al. | Nucleic acid targeting: towards personalized therapy for head and neck cancer | |
| JP2024138296A (ja) | 細胞外小胞を形質転換することを伴う組成物及び方法 | |
| Janowski et al. | The legacy of mRNA engineering: A lineup of pioneers for the Nobel Prize | |
| Vaiani et al. | In vivo vectorization and delivery systems for gene therapies and RNA-based therapeutics in oncology | |
| Liu et al. | Biological response modifier in cancer immunotherapy | |
| Hamdy et al. | MicroRNA: Exploring Their Multifaceted Role in Cancer | |
| CN116218904A (zh) | 一种可提高工程化细胞外泌体中特定核酸分子载量的方法及其应用 | |
| RU2021116984A (ru) | Инкапсулированные полинуклеотиды и способы их применения | |
| Javanmardi et al. | Progresses in microRNA delivery using synthetic nanovectors in cancer therapy | |
| RU2021123104A (ru) | Инкапсулированные полинуклеотиды рнк и способы их применения |